Collin founded Kolosis and has held the role of CEO since September of 2019. With over 20 years’ experience in the medical device industry, Collin has held various leadership roles within marketing, US sales, and international commercial operations for both spine and cardiovascular organizations.

Prior to Kolosis, Collin successfully co-founded and established Centurion Therapeutics, an exclusive partner to MTF’s wound care division. Previous to that venture, Collin spent over 12 years of his career exclusively focused on marketing and sales leadership roles within spine and orthobiologics first at NuVasive and then at Orthofix.

Collin began his device career with global device-maker, Cook Medical, where he held various international commercial positions including President and Representative Director of Cook Japan, based in Tokyo.

Collin received a bachelor’s degree in international politics from Brigham Young University and a law degree from Indiana University, Bloomington.